Among the analysed target genes, nicotinic acetylcholine receptors (CHRNB3, CHRNE, CHRNB1, CHRND) were found, which are targets of drugs against Alzheimer's disease. The gene discussed is CHRNB1; the disease is early-onset autosomal dominant Alzheimer disease.